Evaluation of prognosis in Stage I cutaneous melanoma
- PMID: 625497
- DOI: 10.1097/00006534-197803000-00006
Evaluation of prognosis in Stage I cutaneous melanoma
Abstract
A review of the literature on melanoma indicates that age, sex, size, ulceration, presence of satellites, absence of melanin, and whether or not the tumor is markedly raised above the surface of the surrounding skin are all useful criteria in evaluating the prognosis in Stage I cutaneous melanoma. Histological factors include the tumor type, the mitotic rate, and the maximum thickness of the tumor. The last is accurate for prognosis--objective, reproducible, and directly proportional to the mortality rate. Tumors less than 0.76 mm thick rarely, if ever, metastasize--and it appears that the size of the resection margin can safely be reduced for such thin tumors. The level of invasion (Clark) is less accurate in predicting the mortality.
Comment in
-
The way it really happened: Breslow, Macht, and tumor thickness in melanoma.Plast Reconstr Surg. 2004 Feb;113(2):737-9. doi: 10.1097/01.PRS.0000101736.75562.0A. Plast Reconstr Surg. 2004. PMID: 14758244 No abstract available.
Similar articles
-
Staging and prognosis of melanoma.Semin Cutan Med Surg. 1997 Jun;16(2):113-21. doi: 10.1016/s1085-5629(97)80005-3. Semin Cutan Med Surg. 1997. PMID: 9220550 Review.
-
Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?Ann Plast Surg. 2003 Jun;50(6):601-6. doi: 10.1097/01.SAP.0000069065.00486.1E. Ann Plast Surg. 2003. PMID: 12783009
-
Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.Ann Surg Oncol. 2012 Jun;19(6):1782-9. doi: 10.1245/s10434-012-2265-y. Epub 2012 Feb 14. Ann Surg Oncol. 2012. PMID: 22350600 Clinical Trial.
-
Prognostic Significance of Periadnexal Extension in Cutaneous Melanoma and its Implications for Pathologic Reporting and Staging.Am J Surg Pathol. 2018 Mar;42(3):359-366. doi: 10.1097/PAS.0000000000000999. Am J Surg Pathol. 2018. PMID: 29240580
-
Prognostic factors in patients with localized primary cutaneous melanoma.Acta Dermatovenerol Alp Pannonica Adriat. 2012;21(2):27-31. Acta Dermatovenerol Alp Pannonica Adriat. 2012. PMID: 23000937 Review.
Cited by
-
Outcome of sentinel lymph node biopsy and prognostic implications of regression in thin malignant melanoma.Melanoma Res. 2012 Aug;22(4):302-9. doi: 10.1097/CMR.0b013e328353e673. Melanoma Res. 2012. PMID: 22610274 Free PMC article.
-
Cutaneous malignant melanoma in Scotland.Br J Cancer. 1982 Jul;46(1):75-80. doi: 10.1038/bjc.1982.167. Br J Cancer. 1982. PMID: 7104199 Free PMC article.
-
Cutaneous melanomas exhibiting unusual biologic behavior.World J Surg. 1992 Mar-Apr;16(2):196-202. doi: 10.1007/BF02071521. World J Surg. 1992. PMID: 1561799
-
Study of the histopathological types of cutaneous melanoma in Palmas-TO from 2001 to 2011.An Bras Dermatol. 2015 Sep-Oct;90(5):638-45. doi: 10.1590/abd1806-4841.20153528. An Bras Dermatol. 2015. PMID: 26560208 Free PMC article.
-
Prognostic value of sentinel lymph node biopsy in 121 low-risk melanomas (tumour thickness <1.00 mm) on the basis of a long-term follow-up.Eur J Nucl Med Mol Imaging. 2012 Apr;39(4):581-8. doi: 10.1007/s00259-011-2009-4. Epub 2011 Dec 8. Eur J Nucl Med Mol Imaging. 2012. PMID: 22160198
MeSH terms
LinkOut - more resources
Full Text Sources